Rosen Law Firm & ADMA Biologics

Rosen Law Firm: Rosen Law Firm is investigating potential securities claims and has filed a class action lawsuit against ADMA Biologics for allegedly issuing materially misleading business information.

ADMA Biologics: ADMA Biologics is the primary subject of the class action lawsuits and investigations due to allegations of channel stuffing, undisclosed related-party transactions, and misleading revenue growth, which caused its stock price to decline significantly.

Rosen Law Firm: The Rosen Law Firm is a lead plaintiff in the class action, having filed the first complaint. It is actively recruiting investors and stands to gain from a favorable outcome.

ADMA Biologics: ADMA Biologics is the defendant in the securities class action, accused of making false and misleading statements. The lawsuit and allegations have led to a significant drop in its stock price and could result in substantial financial penalties and reputational harm.